Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

ClinicalTrials.gov ID: NCT07610473

Public ClinicalTrials.gov record NCT07610473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 1:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Double-blind, Randomised, Placebo-controlled Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of DT-101 in Adults With Major Depressive Disorder Receiving Pharmacological Therapy for Depression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

In this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. A placebo looks the drug but contains no medicine. Subjects will attend the clinic for complete general health checks and to complete questionnaires.

Study identification

NCT ID
NCT07610473
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Draig Therapeutics Ltd
Industry
Enrollment
118 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 13, 2026
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027
Last update posted
Aug 11, 2026

2026 – 2027

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Draig Clinical Site Phoenix Arizona 85013 Recruiting
Draig Clinical Site Little Rock Arkansas 72211 Recruiting
Draig Clinical Site Bellflower California 90706 Recruiting
Draig Clinical Site Costa Mesa California 92626 Recruiting
Draig Clinical Site Lafayette California 94549 Recruiting
Draig Clinical Site Hialeah Florida 33016 Recruiting
Draig Clinical Site Orlando Florida 32803 Recruiting
Draig Clinical Site Orlando Florida 32807 Recruiting
Draig Clinical Site Tampa Florida 33607 Recruiting
Draig Clinical Site Tampa Florida 33613 Recruiting
Draig Clinical Site Decatur Georgia 30030 Recruiting
Draig Clinical Site Chicago Illinois 60610 Recruiting
Draig Clinical Site Skokie Illinois 60076 Recruiting
Draig Clinical Site Boston Massachusetts 02130 Recruiting
Draig Clinical Site New York New York 10025 Recruiting
Draig Clinical Site New York New York 10029 Recruiting
Draig Clinical Site Columbus Ohio 43215 Recruiting
Draig Clinical Site Allentown Pennsylvania 18103 Recruiting
Draig Clinical Site Media Pennsylvania 19063 Recruiting
Draig Clinical Site DeSoto Texas 75115 Recruiting
Draig Clinical Site Fort Worth Texas 76104 Recruiting
Draig Clinical Site Bellevue Washington 98007 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07610473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2026 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07610473 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →